Bridging silos for success in pharma marketing
The continuing and increasing pressure on cost of pharmaceuticals, burgeoning regulatory demands and restrictions and ever-growing expectations from Wall Street are putting pharmas under the gun like never before.
The continuing and increasing pressure on cost of pharmaceuticals, burgeoning regulatory demands and restrictions and ever-growing expectations from Wall Street are putting pharmas under the gun like never before.
https://www.reutersevents.com/pharma/sites/all/modules/wysiwyg/plugins/b...">But Eric Rambeaux, VP of Business Development and Head of Screening and Analytics at Solvay Pharmaceuticals, says with a keen eye on market access strategies that bridge silos within pharma, companies can ensure the drugs that are developed and brought to market within the industry will be a success.